Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Progressive osseous heteroplasia controlled by intravenous administration of pamidronate.

Hou JW.

Am J Med Genet A. 2006 Apr 15;140(8):910-3. No abstract available.

PMID:
16532474
2.

Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNAS-based heterotopic ossification.

Adegbite NS, Xu M, Kaplan FS, Shore EM, Pignolo RJ.

Am J Med Genet A. 2008 Jul 15;146A(14):1788-96. doi: 10.1002/ajmg.a.32346.

3.

A case of progressive osseous heteroplasia: a first case in Japan.

Kumagai K, Motomura K, Egashira M, Tomita M, Suzuki M, Uetani M, Shindo H.

Skeletal Radiol. 2008 Jun;37(6):563-7. doi: 10.1007/s00256-008-0469-9.

PMID:
18309480
4.

[Pseudopseudohypoparathyroidism vs progressive osseous heteroplasia in absence of family history].

Pereda A, González Oliva E, Riaño-Galán I, Pérez de Nanclares G.

Med Clin (Barc). 2015 Nov 20;145(10):e25-7. doi: 10.1016/j.medcli.2015.02.009. Epub 2015 Apr 10. Spanish. No abstract available.

PMID:
25865609
5.

Progressive osseous heteroplasia caused by a novel nonsense mutation in the GNAS1 gene.

Goto M, Mabe H, Nishimura G, Katsumata N.

J Pediatr Endocrinol Metab. 2010 Mar;23(3):303-9.

PMID:
20480732
6.

Progressive osseous heteroplasia resulting from a new mutation in the GNAS1 gene.

Chan I, Hamada T, Hardman C, McGrath JA, Child FJ.

Clin Exp Dermatol. 2004 Jan;29(1):77-80.

PMID:
14723729
7.

[Clinical features, mutation of the GNAS1 and pathogenesis of progressive osseous heteroplasia].

Wu FQ, Wang L, Zou JZ, Huang XL, Yuan XY.

Zhonghua Er Ke Za Zhi. 2012 Jan;50(1):10-4. Chinese.

PMID:
22456068
8.

Infantile osteoma cutis as a presentation of a GNAS mutation.

Martin J, Tucker M, Browning JC.

Pediatr Dermatol. 2012 Jul-Aug;29(4):483-4. doi: 10.1111/j.1525-1470.2011.01469.x. Epub 2012 May 21.

PMID:
22612068
9.

Decrease of serum alkaline phosphatase after three cycles of pamidronate disodium in children with severe osteogenesis imperfecta.

Cabral de Menezes Filho H, Rodrigues JM, Radonsky V, Della Manna T, Kuperman H, Steinmetz L, Dichtchekenian V, Damiani D, Setian N.

Horm Res. 2007;68 Suppl 5:207-8. doi: 10.1159/000110676. Epub 2007 Dec 10. No abstract available.

PMID:
18174750
10.

GNAS1 mutations and progressive osseous heteroplasia.

Ahmed SF, Barr DG, Bonthron DT.

N Engl J Med. 2002 May 23;346(21):1669-71. No abstract available.

11.

GNAS1 mutations and progressive osseous heteroplasia.

Farfel Z.

N Engl J Med. 2002 May 23;346(21):1669-71. No abstract available.

PMID:
12030264
12.

The genetic basis of progressive osseous heteroplasia.

Jüppner H.

N Engl J Med. 2002 Jan 10;346(2):128-30. No abstract available.

PMID:
11784882
13.

Progressive osseous heteroplasia is not a Mendelian trait but a type 2 segmental manifestation of GNAS inactivation disorders: A hypothesis.

Happle R.

Eur J Med Genet. 2016 May;59(5):290-4. doi: 10.1016/j.ejmg.2016.04.001. Epub 2016 Apr 4. Review.

PMID:
27058263
14.

GNAS-associated disorders of cutaneous ossification: two different clinical presentations.

Schimmel RJ, Pasmans SG, Xu M, Stadhouders-Keet SA, Shore EM, Kaplan FS, Wulffraat NM.

Bone. 2010 Mar;46(3):868-72. doi: 10.1016/j.bone.2009.11.001. Epub 2009 Nov 10.

15.

Endochondral ossification in a case of progressive osseous heteroplasia in a young female child.

Schrander DE, Welting TJ, Caron MM, Schrander JJ, van Rhijn LW, Körver-Keularts I, Schrander-Stumpel CT.

J Pediatr Orthop B. 2014 Sep;23(5):477-84. doi: 10.1097/BPB.0000000000000045.

PMID:
24626099
16.

[Fibrous dysplasia: overview].

Akasbi N, Abourazzak FE, Talbi S, Tahiri L, Harzy T.

Pan Afr Med J. 2015 May 8;21:21. doi: 10.11604/pamj.2015.21.21.3487. eCollection 2015 May 8. French. No abstract available.

17.

Unilateral progressive osseous heteroplasia.

Santiago F, Vieira R, Cordeiro M, Tellechea O, Figueiredo A.

Eur J Dermatol. 2009 May-Jun;19(3):214-5. doi: 10.1684/ejd.2009.0634. Epub 2009 Feb 12.

PMID:
19213659
18.

Skeletal abnormalities and extra-skeletal ossification in mice with restricted Gsalpha deletion caused by a renin promoter-Cre transgene.

Castrop H, Oppermann M, Mizel D, Huang Y, Faulhaber-Walter R, Weiss Y, Weinstein LS, Chen M, Germain S, Lu H, Ragland D, Schimel DM, Schnermann J.

Cell Tissue Res. 2007 Dec;330(3):487-501. Epub 2007 Oct 6.

PMID:
17922144
19.

Amino-bisphosphonates in heterotopic ossification: first experience in five consecutive cases.

Schuetz P, Mueller B, Christ-Crain M, Dick W, Haas H.

Spinal Cord. 2005 Oct;43(10):604-10.

PMID:
15867938
20.

Activation of Hedgehog signaling by loss of GNAS causes heterotopic ossification.

Regard JB, Malhotra D, Gvozdenovic-Jeremic J, Josey M, Chen M, Weinstein LS, Lu J, Shore EM, Kaplan FS, Yang Y.

Nat Med. 2013 Nov;19(11):1505-12. doi: 10.1038/nm.3314. Epub 2013 Sep 29.

Supplemental Content

Support Center